Digital health firm Pear goes public, raising $175 millionPear Therapeutics has completed its merger with blank cheque company Thimble Point Acquisition Corp, claiming a Nasdaq listing Share XDigital health firm Pear goes public, raising $175 millionhttps://pharmaphorum.com/news/digital-health-firm-pear-goes-pubic-raising-175-million/
Pear claims breakthrough tag for alcohol use disorder DTxDigital health company Pear Therapeutics has won FDA breakthrough device status for reSET-A, its development-stage prescription digital therapeutic Share XPear claims breakthrough tag for alcohol use disorder DTxhttps://pharmaphorum.com/news/pear-claims-breakthrough-tag-for-alcohol-use-disorder-dtx/
Digital therapeutic cuts opioid use disorder care costs, says studyA real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it Share XDigital therapeutic cuts opioid use disorder care costs, says studyhttps://pharmaphorum.com/news/digital-therapeutic-cuts-opioid-use-disorder-care-costs-says-study/
NIH starts trial of Pear, Chess apps for opioid use disorderPatient recruitment has begun in a National Institutes of Health (NIH) trial of two digital therapeutics (DTx) for Share XNIH starts trial of Pear, Chess apps for opioid use disorderhttps://pharmaphorum.com/news/nih-starts-trial-of-pear-chess-apps-for-opioid-use-disorder/
DTx company Pear shapes public listing with $1.6bn SPAC mergerDigital health company Pear Therapeutics has foregone the traditional initial public offering (IPO) route to a stock exchange Share XDTx company Pear shapes public listing with $1.6bn SPAC mergerhttps://pharmaphorum.com/news/dtx-company-pear-shapes-public-listing-with-1-6bn-spac-merger/
Ohio is third state to fund Pear’s digital therapeutics to tackle addictionA third US state has agreed to fund Pear Therapeutics’ digital therapeutics (DTx) to treat people with substance Share XOhio is third state to fund Pear’s digital therapeutics to tackle addictionhttps://pharmaphorum.com/news/ohio-is-third-state-to-fund-pears-digital-therapeutics-to-tackle-addiction/
Digital therapies for opioid use disorder need more data, says ICERThere isn’t enough evidence to suggest that digital therapies for people with opioid use disorder (OUD) can improve Share XDigital therapies for opioid use disorder need more data, says ICERhttps://pharmaphorum.com/news/digital-therapies-for-opioid-use-disorder-need-more-data-says-icer/
Pear rolls out digital therapy for schizophrenia under FDA’s COVID-19 schemePear Therapeutics has started a limited launch of its digital therapeutic for people living with schizophrenia under the Share XPear rolls out digital therapy for schizophrenia under FDA’s COVID-19 schemehttps://pharmaphorum.com/news/pear-rolls-out-digital-therapy-for-schizophrenia-under-fdas-covid-19-scheme/
Sandoz says ‘no’ to Pear Therapeutics’ digital apps, handing back rightsNovartis has made no secret of its desire to become a leader in digital therapeutics (DTx), but that Share XSandoz says ‘no’ to Pear Therapeutics’ digital apps, handing back rightshttps://pharmaphorum.com/news/sandoz-says-no-to-pear-therapeutics-digital-app-handing-back-rights/
